Section Review: Prevention and treatment of respiratory distress syndrome: Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis

References

• SOLL 12F, MCQUEEN MM: Respiratory distress syndrome. In: Effective care of the newborn infant. Sinclair J, Bracken M (Eds.). Oxford University Press (1992):323–358.
   Google Scholar
• JOBE A: Pulmonary surfactant therapy. New Engl. J. Med. (1993) 328:861–868.
   PubMed Web of Science ®Google Scholar
• PARKER JC, HERNANDEZ LA, PEAVY KS: Mechanisms of •ventilation-induced lung injury. Grit. Care Med. (1993)21:131-143. Carefully reviews the mechanisms that cause acute lung injury.
   Google Scholar
• MILLER HC, FUTRAKUL P: Birth weight, gestational age, and sex as determining factors in the incidence of respiratory distress syndrome of prematurely-born in-fants. J. Pediatr. (1968) 72:028–635.
   Google Scholar
• JAMES SL: Prenatal events and respiratory distress syn-drome. New Engl. J. Med. (1975) 292:1291–1292.
   PubMed Web of Science ®Google Scholar
• THURLBECK WM: Prematurity and the developing lung. PertnatoL (1992) 19:497–519.
   Google Scholar
• DIMAIO M, GIL J, CIUREA D, KATTANM: Structural matu-ration of the human fetal lung: a morphometric study of the development of air-blood barriers. Pediatr. Res. (1989) 26:88–93.
   PubMed Web of Science ®Google Scholar
• LANGSTON C, IUDA K, REED M, THURLBECK WM: Human •lung growth in late gestation and the neonate. Am. Rev.Dis. (1984) 129:607-613. Excellent histopathologic pictures of lung development.
   Google Scholar
• JACKSON RM: Molecular, pharmacologk, clinical as-pects of oxygen-induced lung injury. Clin. Chest. Med. (1990) 11:73-86. Outstanding review of how oxygen damages lung tissue.
   Google Scholar
• HEFFNER JE, REPINE JE: Pulmonary strategies of lung •antioxidant defense. Am. Rev. Resp. Dis. (1989) 140:531-554. Good review of how the body protects itself from oxygen-induced lung injury.
   Google Scholar
• FRANK L, GROSECLOSE EE: Preparation from birth into an 02-rich environment: the antioxidant enzymes in developing rabbit lung. Pediatr. Res. (1984) 18:240–244.
   PubMed Web of Science ®Google Scholar
• FRANK L, SOSENKO IRS: Prenatal development of lung antioxidant enzymes in four species. J. Pediatr. (1987) 110:106–110.
   PubMed Web of Science ®Google Scholar
• COALSON JJ, WINTER VT, GERSTMANN DR, ETAL.: Patho-physiologic, morphometric and biochemical studies of the premature baboon with bronchopuimonary dys-plasia. Am. Rev. Respir. Dis. (1992) 145:872–881.
   Google Scholar
• COALSON JJ, KNUEL TJ, PRIHODA TJ, DELEMOS RA: Dif-fuse alveolar damage in evolution of bronchopulmon-ary dysplasia in the baboon. Pediatr. Res. (1988) 24:357–366.
   PubMed Web of Science ®Google Scholar
• LONG WA, ZUCKER JA, KRAYBILL EN: Symposium on synthetic surfactant if: health and developmental out-comes at one year. J. Pediatr. (1995) 126:S1–98.
   PubMed Web of Science ®Google Scholar
• SURVANTA MULTIDOSE STUDY GROUP: Two year follow-up of infants treated for neonatal respiratory distress with bovine surfactant. J. Pediatr. (1994) 124:962–967.
   PubMed Web of Science ®Google Scholar
• WUNG JT, JAMES LS, KILCHEVSKY E, JAMES E: Manage-ment of infants with severe respiratory failure and persistence of the fetal circulation without hyperventi-lation. Pediatrics (1985) 76:488–494.
   PubMed Web of Science ®Google Scholar
• CLARK RH: High-frequency ventilation. J. Pediatr. (1994)124:661–670.
   PubMed Web of Science ®Google Scholar
• MEREDITH KS, DELFMOS RA, COALSSON JJ, ETAL.: Role ••of lung injury in the pathogenesis of hyaline membranedisease in premature baboons. J. Appl. Physiol. (1989) 66:2150-2158. Landmark article showing that RDS is, at least in part, due to ventilator-induced lung injury.
   Google Scholar
• JACKSON JC, TRUOG WE, STANDAERT TA, ETAL.: Reduc-tion in lung injury after combined surfactant and high-frequency ventilation. Am.J. Respir. Grit. CareMed. (1994) 150:534–539.
   Google Scholar
• THE VICTORIAN INFANT COLLABORATIVE STUDY GROUP: Improvement of outcome for infants of birth weight under 1000 g. Arch. Dis. Child. (1991) 66:765–769.
   PubMed Web of Science ®Google Scholar
• HACK M, HORBAR JD, MALLOY MH, TYSON JE, WRIGHTE, WRIGHT L: Very low birth weight outcomes of the National Institute of Child Health and Human Develop-ment Neonatal Network. Pediatrics (1991) 87:587–597.
   PubMed Web of Science ®Google Scholar
• IKEGAMI M, BERRY D, ELKADY T, ETAL.: Corticosteroidsand surfactant change lung function and protein leaks In lungs of ventilated premature rabbits. J. Chn. Invest. (1987) 79:1371–1378.
   Google Scholar
• GROSS I, DYNIA DW, WILSON CM, INGLESTON LD, GE-WOLB IH, ROONEY SA: Glucocorticoid-thyroid hor-mone interaction. Ped. Res. (1984) 18:191–196.
   PubMed Web of Science ®Google Scholar
• BARNES P, JACOBS M, ROBERTS JM: Glucocorticoids preferentially increase fetal alveolar P-adrenorecep-tors: autoradiographic evidence. Pediatr. Res. (1984) 18:1191–1194.
   PubMed Web of Science ®Google Scholar
• MENDELSON CR, CHEN C, BOGGARAM V, ZACHARIAS SNYDER JM: Regulation of synthesis of the major surfac-tant apoprotein in fetal rabbit lung tissue. J. Biol. Chem. (1986) 261:9938–9943.
   PubMed Web of Science ®Google Scholar
• IKEGAMI M, JOBE A, BERRY D: A protein that inhibitssurfactant in respiratory distress syndrome. Biol. Neo-nate (1986)50121–129.
   Google Scholar
• LIGGINS GC, HOWIE RN: A control trial of antepartumglucocorticoid treatment for prevention of the corticos-teroid distress syndrome in premature infants. Pediat-rics (1972) 50:515–520.
   PubMed Web of Science ®Google Scholar
• JOBE AH: Fetal lung development, test for maturation,induction of maturation and treatment. In: Maternal Fetal Medicine. Creasy RIC, Resnik R (Eds.) (1994):423–441.
   Google Scholar
• MORALES WJ, DIEBEL P, LAZAR A, FADROZNY D: Theeffect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome in premature gestations with premature rupture of mem-branes. Am. J. Obstet. Gynecol. (1986) 154:591–595.
   PubMed Web of Science ®Google Scholar
• FARREL EE, SILVER RK, KIMBERLIN LV, WOLF ES, DUSHCJM: Impact of antenatal dexamethasone administration on respiratory distress syndrome in surfactant-treated Infants. Am. J. Obstet. Gynecol. (1989) 161:628–633.
   PubMed Web of Science ®Google Scholar
• KWONG MS, EGAN EA: Reduced incidence of hyaline membrane disease in extremely premature infants fol-lowing delay of delivery in mother with premature labor: use of ritodrine and betamethasone. Pediatrics (1986) 78:767–774.
   PubMed Web of Science ®Google Scholar
• CUNNINGHAM D, EVANS E: The effects of betamethasone on maternal cellular resistance to infection. Am .J. Obstet. Gynecol. (1991) 165:610–615.
   PubMed Web of Science ®Google Scholar
• CROWLEY P, CHALMERS I, KEIRGE MJN: The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. Br. Obstet. Gynecol. (1990) 97:11–30.
   PubMedGoogle Scholar
• MACARTHUR BA, HOWIE RN, DEFOEIE JA, NZRGONNZRM, ELICINS J: Cognitive and psychological develop-ment of 4-year-old children whose mothers were treated antenatally with betamethasone. Pediatrics (1981) 68:638–643.
   PubMed Web of Science ®Google Scholar
• MACARTHUR BA, HOWIE RN, DEF01.1k. JA, NZRGON NZRM, ELKINS J: School progress and cognitive develop-ment of 6-year-old children whose mothers were treated antenatally with betamethasone. Pediatrics (1982) 70:99–105.
   Google Scholar
• DOYLE LW, KITCHEN 'WH, FORD GW, RICKARDS AL, LISSENDEN JV, RYAN MM: Effects of antenatal steroid therapy on mortality and morbidity in very low birth weight infants. J. Pediatr. (1986) 108:287–292.
   PubMed Web of Science ®Google Scholar
• COLLABORATIVE GROUP ON ANTENATAL STEROID THERAPY: Effects on antenatal dexamethasone admini-stration in the infant: long term follow-up. J. Pediatr. (1984) 104:259–267.
   PubMed Web of Science ®Google Scholar
• GARLAND JS, BUCK R, LEVITON A: Effect of maternal g,lucocorticoid exposure on risk of severe intraven-tricular hemorrhage in surfactant-treated preterm in-fants. J. Pediatr. (1995) 126:272–277.
   PubMed Web of Science ®Google Scholar
• KARI MA, HALLMAN M, ERONEN M, TERAMO K, VIRTANEN M, KONISTO M, IKONEN RS: Prenatal betamethasone In conjunction with rescue therapy of human surfactant. A randomized controlled multicenter study. Pediatrics (1993) 93:730–736.
   Web of Science ®Google Scholar
• GROSS I: Regulation of fetal lung maturation. Am. J. Physiol. (1990) 259:L337–344.
   PubMed Web of Science ®Google Scholar
• MOYA FR, GROSS I: Combined hormonal therapy of •prevention of respiratory distress syndrome. Semin.Perinatol. (1993) 17:267-274. Excellent review of how thyrotropin-releasing hormone accelerates lung maturation.
   Google Scholar
• KNIGHT DB, LIGGINS GC, WEALTHALL SR: A randomized controlled trial of antepartum thyrotropin-releasing hormone and betamethasone in prevention of respira-tory disease in preterm infants. Am. J. Obstet. Gynecol. (1994) 171:11–16.
   PubMed Web of Science ®Google Scholar
• AUSTRALIAN COLLABORATIVE STUDY GROUP: Austra-lian collaborative trial of antenatal thyrotropin-releas-ing hormone (ACTOBAT) for prevention of neonatal respiratory disease. Lancet (1995) 345:877–882.
   PubMed Web of Science ®Google Scholar
• GOERKE J: Surfactant and lung mechanics. In: Pulmo-nary surfactant: from molecular biology to clinical practice. Robertson B, Vangolde LMG, Batenburg JJ (Eds.). Elsevier, Amsterdam (1993):165–192.
   Google Scholar
• KING RJ, CLEMENTS JA: Surface active materials from dog lung: composition and physiological correlations. Am. Physiol. (1972) 223:715-726. ISO 65.
   Google Scholar
• WEAVER T, WHITSETT JA: Function and regulation of expression of pulmonary surfactant associated pro-teins. Biochem. J. (1991) 273:249–255.
   PubMed Web of Science ®Google Scholar
• FUJIWARA T, MAETA H, CHIDA S, MORITA T, WATABE Y, ABE T: Artificial surfactant therapy in hyaline mem-brane disease. Lancet (1980) 1:55–59.
   PubMed Web of Science ®Google Scholar
• JOBE A, IKEGAMI M: Surfactant for the treatment of respiratory distress syndrome. Am. Rey. Respir. Dis. (1987) 136:1256–1275.
   PubMed Web of Science ®Google Scholar
• HOLM BA, WARING AJ: Designer surfactants: the nextgeneration in surfactant replacement. Clin. Perinatot (1993) 20:813–829.
   PubMed Web of Science ®Google Scholar
• DAVIS JM: Surfactant administration strategies: howfast, how much, how often? Im Surfactant replacement therapy. Frantz I (Ed.). A clinical symposium sponsored by Ross Laboratories (1993).
   Google Scholar
• KENDIG JW, NOTHER RH, COX C, ET AL.: A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns less than 30 weeks' gestation. New Engl. J. Med. (1991) 324:865–871.
   Google Scholar
• KATTWINKEL J, BLOOM B, DELMORE P, ET AL.: Prophy-lactic administration of calf lung surfactant extract is more effective than early treatment of RDS in neonates 29–32 weeks' gestation. Pediatrics (1993) 92:90–98.
   Google Scholar
• MERRITT TA, HALLMAN M, BERRY C, ETAL.: Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity. J. Pediatr (1991) 118:581–594.
   Google Scholar
• THE OSIRIS COLLABORATIVE GROUP: Early versus de-layed neonatal administration of synthetic surfactant - the judgement of osrus. Lancet (1992) 340:1363–1369.
   PubMed Web of Science ®Google Scholar
• SNIEDER S, IKEGAMI M, YAMADA T, ET AL.: Decreased surfactant response following the onset of mechanical ventilation in preterm rabbits. Pediatr. Res. (1989) 25:326A.
   Google Scholar
• GOLDSMITH IS, GREENSPAN JB, RUBENSTEIN DS, WOLF-SON MR, SHAFFER TH: Immediate improvement in lung volume after exogenous surfactant alveolar recruit-ment versus increased distension. J. Pediatr. (1991) 119:424–428.
   PubMed Web of Science ®Google Scholar
• DUNN MS, SHENNAN AT, POSSMAYER F: Single versus multiple-dose surfactant replacement therapy in neo-nates of 30-36 weeks' gestation with respiratory distress syndrome. Pediatrics (1990) 86:564–571.
   PubMed Web of Science ®Google Scholar
• SPEER CP, ROBERTSON B, CURSTEDT T, ET AL.: Random-ized European multicenter trial of surfactant replace-ment therapy for severe neonatal respiratory distress syndrome. Single versus multiple dose of Curosurf. Pediatrics (1992) 89:13–20.
   Google Scholar
• PRAMANIK A, DHANIREDDY R, HALLMAN M, ET AL.: Ran-domized comparison of two versus four doses of syn-thetic surfactant in 548 infants with RDS weighing at least 1250 grams. Pediatrics Res. (1992) 31:217A.
   Google Scholar
• JACKSON JC, TRUOG WE, STANDAERT TA, MURPHY JH, JUUL SE, CHI E, HILDEBRANTJ, HODGSON WA: Reduction In lung injury after combined surfactant and high-fre-quency ventilation. Am. J. Respir. Crit. Care Med. (1994) 150:534–539.
   PubMed Web of Science ®Google Scholar
• FROESE AB, MCCULLOCH PR, SUQIURA M, VACLAVIK S,POSSMAYER F, MOLLER F: Optimizing alveolar expan- sion prolongs the effectiveness of exogenous surfac-tant therapy in the adult rabbit. Am. Rev. Respir. Dis. (1993) 148:569–577.
   PubMed Web of Science ®Google Scholar
• WEGMAN EM: Annual summary of vital statistics - 1990.Pediatrics (1991) 88:1081–1092.
   PubMed Web of Science ®Google Scholar
• CORBET A: Clinical trials of synthetic surfactant in the •respiratory distress syndrome of premature infants.Clin. Pertnatol. (1993) 20:737-760. Comprehensive review of clinical trials evaluating synthetic surfac-tants.
   Google Scholar
• MERCIER CE, SOLL RF: Clinical trials of natural surfactant itextract in respiratory distress syndrome. Clin. PerinatoL (1993) 20:711-735. Comprehensive review of clinical trials evaluating natural surfac-tants.
   Google Scholar
• SCHWARTZ RM, LUBH AM, SCANLON JW, KELLOGG RT: Effect of surfactant on morbidity, mortality and re-source use in newborn infants weighing 500 to 1500g. New Engl. J. Med. (1994) 330:1476–1480.
   PubMed Web of Science ®Google Scholar
• HALLMAN M, MERRITT TA, BAY K: The fate of exogenous surfactant in neonates with respiratory distress syn-drome. Clinical Pharmacokinetics (1994) 26:215–232.
   PubMed Web of Science ®Google Scholar
• SOLL RE, SINCLAIR JC, BRACKEN MB: Natural surfactantextract versus synthetic surfactant meta-analysis of randomized controlled trials. Pediatr. Res. (1995) Abstract 1628:274A.
   Google Scholar
• REVAK SD, COCHRANE CG, HELDT GP, ALBERTS MS, METTER A, mERRrrr TA: Efficacy of KL-4 surfactant in premature infant monkeys. Pediatr. Res. (1995) Abstract 2067:347A.
   Google Scholar
• FRANK L: Antioxidants, nutrition and bronchopulmon-ary dysplasia. Clin. Perinatol. (1992) 19:541–562.
   PubMed Web of Science ®Google Scholar
• GRIGG J, BARBER A, SILVERMAN M: Bronchoahmolar lavage fluid glutathione in intubated premature infants. Arch. Dis. Child (1993) 69:49–51.
   PubMed Web of Science ®Google Scholar
• SMITH LJJ, ANDERSON M, SHAMSUDDIN MIR: Glutathionelocalization and distribution after intratracheal instil-latiom implications for treatment. Am. Rev. Respir. (1992) 145:153–159.
   PubMed Web of Science ®Google Scholar
• PHELPS DL, ROSENBAUM AL, ISENBERG SJ: Tocopherolefficacy and safety for preventing retinopathy of pre-maturity: a randomized, controlled, double-masked trial. Pediatrics (1987) 79:489–500.
   PubMed Web of Science ®Google Scholar
• LORCH V, MURPHY MD, HOERSTEN LR, HARRIS E, FIT-GERAL J, SHINA SN: Unusual syndrome among prema-ture infants: association with a new intravenous vitamin E product. Pediatrics (1985) 75:598–602.
   PubMed Web of Science ®Google Scholar
• JOHNSON L, BOWEN FR, ABBASI S, ET AL.: Relationship of prolonged pharmacologic serum levels of vitamin E to incidence of sepsis and necrotizing enterocolitis in Infants with birth weight 1500 grams or less. Pediatrics (1985) 75:619–638.
   Google Scholar
• PELIOWSKI A, FINER NN, ETCHES PC, TIERNEY AJ, RYANCA: Inhaled nitric oxide for premature infants after prolonged rupture of the membranes. J. Pediatr. (1995) 126:450–453.
   PubMed Web of Science ®Google Scholar
• ABMAN SH, KINSELLA JP, SCHAFFER MS, WILKENING RB:Inhaled nitric oxide in the management of a premature newborn with severe respiratory distress and pulmo-nary hypertension. Pediatrics (1993) 92:606–609.
   PubMed Web of Science ®Google Scholar
• MONCADA S, PALMER RMJ, HIGGS EA: Nitric oxide: Physi-ology, pathophysiology and pharmacology. Pharmacol. Rev. (1991) 43:109–142.
   PubMed Web of Science ®Google Scholar
• MONCADA S, HIGGS A: The L-Arginine nitric oxide pathway. New Engl. J. Med. (1993) 329:2002-2012. Wonderful figures on how nitric oxide works.
   Google Scholar
• GASTON B, DRAZEN JM, LOCALZO J, STALMER JS: Thebiology of nitrogen oxides in the airways. Am. I Crit. Care Med. (1994) 149:538–551.
   PubMed Web of Science ®Google Scholar
• SHAFFER TH, WOLFSON MR: Principles and applications of liquid breathing: water babies revisited. flu The yearbook of Neorzatal and PerinatalMedicine. Haus MH, Fanaroff AA (Eds.) (1994. Comprehensive review of the use of liquid ventilation by a leader in this field of research.
   Google Scholar
• HALLMAN M, MERRITT TA, JARVENPAA AL, ET AL.: Exoge-nous human surfactant for treatment of severe respira-tory distress syndrome: a randomized prospective clinical trial. J. Pediatr. (1985) 106:963–969.
   Google Scholar
• NOACK G, BEGGREN P, CURSTEDT T, ET AL.: Severeneonatal respiratory distress syndrome treated with the isolated phospholipid fraction of natural surfac-tant. Acta Pediatr. Scand. (1987) 76:15–33.
   Google Scholar
• ENHORING G, SHENNAN A, POSSMAYER F, ET AL.: Pre-vention of neonatal respiratory distress syndrome by tracheal instillation of surfactant a randomized clinical Pediatrics (1985) 76:145–153.
   Google Scholar
• KWONG MS, EGAN EA, NUTTER RH, ET AL.: Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants. Pediatrics (1985) 76:585–592.
   Google Scholar
• GORTNER L, POHLANDT F, DISSE B, ET AL.: Effects of bovine surfactant in premature lambs after intra-tra-cheal application. Eur. J. Pediatr. (1990) 149:280–283.
   Google Scholar
• MORLEY CJ, BANGHAM AD, MILLER N, ET AL.: Dry artifi-cial surfactant and its effect on very premature babies. Lancet (1981) 1:48–64.
   Google Scholar
• DLTRAND DJ, CLYMAN RI, HEYMANN MA, ET AL.: Effectsof protein-free, synthetic surfactant on survival and pulmonary function in preterm lambs. J. Pediatr. (1985) 107:775–780.
   Google Scholar